ChromaCode Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 78

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $38M

  • Investors
  • 13

ChromaCode General Information

Description

Developer of a molecular diagnostics technology designed to connect patients to the right treatment through smarter, more accessible diagnostics. The company's technology blends signal processing and tailored chemistry to allow for multiplexed, low-cost chemistry that integrates into existing laboratory workflows, enabling laboratories to carry out cost-effective testing of multiple targets in a single sample on common, existing quantitative polymerase chain reaction instrumentation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 2330 Faraday Avenue
  • Suite 100
  • Carlsbad, CA 92008
  • United States
+1 (442) 000-0000

ChromaCode Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ChromaCode Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series D) 27-Feb-2023 $38M 000.00 00000 Completed Generating Revenue
4. Grant 16-Mar-2021 00000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 03-Dec-2020 0000 000.00 0000 Completed Generating Revenue
2. Later Stage VC (Series B) 25-Apr-2017 $12M $14.2M 0000 Completed Generating Revenue
1. Early Stage VC (Series A1) 13-Aug-2015 $2.2M $2.2M 00.00 Completed Generating Revenue
To view ChromaCode’s complete valuation and funding history, request access »

ChromaCode Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D-2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series D-1 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series C 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 17,251,462 $0.000100 $0.06 $0.7 $0.7 1x $0.7 9.53%
Series A1 10,805,082 $0.000100 $0.02 $0.24 $0.24 1x $0.24 5.97%
To view ChromaCode’s complete cap table history, request access »

ChromaCode Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular diagnostics technology designed to connect patients to the right treatment through smarter, mor
Diagnostic Equipment
Carlsbad, CA
78 As of 2023
000.00
0000 0000-00-00
00000000000 000.00

00000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
00000 0000000000 000
San Diego, CA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim venia
00000 0000000000 000
Minnetonka, MN
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ChromaCode Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pleno Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
MedNet (Other Healthcare Technology Systems) Venture Capital-Backed Minnetonka, MN 00 000.00 00000000000 000.00
Biofidelity. Venture Capital-Backed Cambridge, United Kingdom 00 000.00 0000000000 0 000.00
Bio-Rad Laboratories Corporation Hercules, CA 0000 00.000 000000000 00.000
Qiagen Formerly VC-backed Hilden, Germany 0000 00000 000000&0
To view ChromaCode’s complete competitors history, request access »

ChromaCode Patents

ChromaCode Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3987056-A1 Methods for differentially quantifying nucleic acids Pending 24-Jun-2019 0000000000
US-20200399677-A1 Methods for differentially quantifying nucleic acids Pending 24-Jun-2019 0000000000
EP-3987056-A4 Methods for differentially quantifying nucleic acids Pending 24-Jun-2019 0000000000 0
EP-3847181-A1 Universal tail primers with multiple binding motifs for multiplexed detection of single nucleotide polymorphisms Pending 07-Sep-2018 0000000000
US-20210189473-A1 Universal tail primers with multiple binding motifs for multiplexed detection of single nucleotide polymorphisms Pending 07-Sep-2018 C12Q1/6818
To view ChromaCode’s complete patent history, request access »

ChromaCode Executive Team (13)

Name Title Board Seat Contact Info
Mark McDonough Chief Executive Officer & Board Member
Aditya Rajagopal Ph.D Co-Founder, Chief Technical Officer, Chief Financial Officer and Board Member
Chris MacDonald Ph.D Chief Scientific Officer
Paul Flook Ph.D Chief Research and Development Officer
Brett Brown Vice President, Finance and Administration
You’re viewing 5 of 13 executive team members. Get the full list »

ChromaCode Board Members (11)

Name Representing Role Since
Carol Gallagher MD New Enterprise Associates Chairman 000 0000
James Blair Ph.D Domain Associates Board Member 000 0000
Jenny Yip Adjuvant Capital Board Member 000 0000
Justin Klein MD Vensana Capital Board Member 000 0000
Kevin O'Boyle ChromaCode Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

ChromaCode Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ChromaCode Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Global Brain Venture Capital Minority 000 0000 000000 0
Shimadzu Corporation Minority 000 0000 000000 0
Vensana Capital Venture Capital Minority 000 0000 000000 0
XPRIZE Impact Investing 000 0000 000000 0
Adjuvant Capital Impact Investing Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »